Key Takeaways:
5-Year Pilot Program: Starting as early as 2026, Medicaid and Medicare may opt to cover GLP-1 weight-loss drugs like Ozempic and Wegovy, expanding access beyond diabetes-related conditions.
Big Costs, Big Market: The drugs run up to $7,000 per year, with analysts...
Key Takeaways:
Record-Breaking Growth: Texas added 195,600 jobs in the past year, leading the nation in employment gains.
Pro-Business Climate: Governor Abbott’s commitment...
